Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Honma

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Oncology Letters|February 14, 2018
TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate-induced growth inhibition in pancreatic cancer cellsFumiyoshi Ikejiri, Yoshio Honma, Takashi Kasukabe, et al.
International Journal of Oncology|April 6, 2018
Cotylenin A and tyrosine kinase inhibitors synergistically inhibit the growth of chronic myeloid leukemia cellsFumiyoshi Ikejiri, Yoshio Honma, Takahiro Okada, et al.
Anticancer Research|August 5, 2003
Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cellsYuri Yamamoto-Yamaguchi, Junko Okabe-Kado, Takashi Kasukabe, et al.
Gynecologic Oncology|August 23, 2005
Antitumor effect of cotylenin A plus interferon-alpha: possible therapeutic agents against ovary carcinomaYoshio Honma, Takashi Kasukabe, Takao Yamori, et al.
Breast Cancer Research : BCR|February 7, 2006
Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenograftsTakashi Kasukabe, Junko Okabe-Kado, Nobuo Kato, et al.
International Journal of Oncology|November 19, 2014
Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cellsTakashi Kasukabe, Junko Okabe-Kado, Nobuo Kato, et al.
International Journal of Oncology|December 21, 2012
Inhibition of rapamycin-induced Akt phosphorylation by cotylenin A correlates with their synergistic growth inhibition of cancer cellsTakashi Kasukabe, Junko Okabe-Kado, Yu Haranosono, et al.
International Journal of Oncology|January 23, 2016
Tamoxifen enhances the differentiation-inducing and growth-inhibitory effects of all-trans retinoic acid in acute promyelocytic leukemia cellsKoji Adachi, Yoshio Honma, Takaaki Miyake, et al.
Cancer Research|July 4, 2003
Cotylenin A, a differentiation-inducing agent, and IFN-alpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude miceYoshio Honma, Yuki Ishii, Yuri Yamamoto-Yamaguchi, et al.
Tumori|June 11, 2013
Antitumor effect of Japanese apricot extract (MK615) on human cancer cells in vitro and in vivo through a reactive oxygen species-dependent mechanismMiho Hattori, Koshi Kawakami, Miho Akimoto, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Oncology Letters|February 14, 2018
TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate-induced growth inhibition in pancreatic cancer cellsFumiyoshi Ikejiri, Yoshio Honma, Takashi Kasukabe, et al.
International Journal of Oncology|April 6, 2018
Cotylenin A and tyrosine kinase inhibitors synergistically inhibit the growth of chronic myeloid leukemia cellsFumiyoshi Ikejiri, Yoshio Honma, Takahiro Okada, et al.
Anticancer Research|August 5, 2003
Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cellsYuri Yamamoto-Yamaguchi, Junko Okabe-Kado, Takashi Kasukabe, et al.
Gynecologic Oncology|August 23, 2005
Antitumor effect of cotylenin A plus interferon-alpha: possible therapeutic agents against ovary carcinomaYoshio Honma, Takashi Kasukabe, Takao Yamori, et al.
Breast Cancer Research : BCR|February 7, 2006
Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenograftsTakashi Kasukabe, Junko Okabe-Kado, Nobuo Kato, et al.
International Journal of Oncology|November 19, 2014
Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cellsTakashi Kasukabe, Junko Okabe-Kado, Nobuo Kato, et al.
International Journal of Oncology|December 21, 2012
Inhibition of rapamycin-induced Akt phosphorylation by cotylenin A correlates with their synergistic growth inhibition of cancer cellsTakashi Kasukabe, Junko Okabe-Kado, Yu Haranosono, et al.
International Journal of Oncology|January 23, 2016
Tamoxifen enhances the differentiation-inducing and growth-inhibitory effects of all-trans retinoic acid in acute promyelocytic leukemia cellsKoji Adachi, Yoshio Honma, Takaaki Miyake, et al.
Cancer Research|July 4, 2003
Cotylenin A, a differentiation-inducing agent, and IFN-alpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude miceYoshio Honma, Yuki Ishii, Yuri Yamamoto-Yamaguchi, et al.
Tumori|June 11, 2013
Antitumor effect of Japanese apricot extract (MK615) on human cancer cells in vitro and in vivo through a reactive oxygen species-dependent mechanismMiho Hattori, Koshi Kawakami, Miho Akimoto, et al.
Pageof 6